Roxanne Lagano - Zoetis President

ZTS -- USA Stock  

USD 125.37  1.69  1.37%

Ms. Roxanne Lagano is Executive Vice President, Chief Human Resources Officer and Communications of Zoetis Inc. Ms. Lagano has served as our Executive Vice President and Chief Human Resources Officer since November 2012 and was given responsibility for corporate communications in 2015. Prior to joining Zoetis, Ms. Lagano was Senior Vice President, Global Compensation, Benefits and Wellness for Pfizer. Ms. Lagano joined Pfizer in 1997 and held various positions, including Senior Director, Business Transactions, Pfizer Worldwide Human Resources.
Age: 53  President Since 2015      
Lagano joined Pfizer in 1997 and held various positions, including Senior Vice President, Pfizer Global Compensation, Benefits and Wellness; and Senior Director, Business Transactions, Pfizer Worldwide Human Resources.

Roxanne Lagano Latest Insider Activity

Management Efficiency

The company has Return on Asset of 12.56 % which means that on every $100 spent on asset it made $12.56 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 62.6 % implying that it generated $62.6 on every 100 dollars invested.
The company has 6.65B in debt with debt to equity (D/E) ratio of 275.9 . This implies that the company may be unable to create cash to meet all of its financial commitments. Zoetis has Current Ratio of 4.09 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.

Similar Executives

Showing few of many executives


Jeffrey NeedhamPerrigo Company plc
Alok SonigDr Reddys Laboratories Ltd
M RamanaDr Reddys Laboratories Ltd
Marion McCourtRegeneron Pharmaceuticals
Marc CouckePerrigo Company plc
Michael AbermanRegeneron Pharmaceuticals
Jatin ShahPerrigo Company plc
Thomas GraneyVertex Pharmaceuticals Incorpor
Umang VohraDr Reddys Laboratories Ltd
Charles MilsteinVertex Pharmaceuticals Incorpor
Ian SmithVertex Pharmaceuticals Incorpor
Louis YuPerrigo Company plc
James MichaudPerrigo Company plc
Thomas FarringtonPerrigo Company plc
Svend AndersenPerrigo Company plc
Scott JamisonPerrigo Company plc
Kimberly WhiteVertex Pharmaceuticals Incorpor
Samiran DasDr Reddys Laboratories Ltd
Sripada ChandrasekharDr Reddys Laboratories Ltd
Jay MarkowitzRegeneron Pharmaceuticals
Christopher FenimoreRegeneron Pharmaceuticals

Entity Summary

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. The company was founded in 1952 and is headquartered in Parsippany, New Jersey. Zoetis operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 10000 people.Zoetis (ZTS) is traded on BATS Exchange in USA and employs 10,000 people.

Zoetis Leadership Team

Roman Trawicki, Executive Vice President and Presidentident of Global Manufacturing and Supply
Kristin Peck, Executive VP and President of U.S. Operations
William Steere, Independent Director
Roxanne Lagano, Chief Human Resource Officer, Executive Vice President
Linda Rhodes, Director
Frank DAmelio, Director
Robert Scully, Independent Director
Clinton Lewis, Executive VP and President of International Operations
Stefan Weiskopf, Executive Vice President and Area President of the Asia Pacific, Australia and New Zealand
Sanjay Khosla, Independent Director
Paul Herendeen, CFO and Executive VP
Catherine Knupp, President of RandD and Executive VP
Michael McCallister, Non-Executive Chairman of the Board
Paul Bisaro, Director
Alejandro Bernal, Executive Vice President and Area President of the Europe, Africa and Middle East region
Willie Reed, Director
Joyce Lee, Executive Vice President and Area President of the Canada and Latin America region
Glenn David, Acting CFO and Sr. VP
Sandra Beaty, Executive Vice President - Corporate Affairs
William Doyle, Director
Andrew Fenton, Executive Vice President CIO
Gregory Norden, Independent Director
Louise Parent, Director
Heidi Chen, Executive Vice President General Counsel, Corporate Secretary
Juan Alaix, CEO and Director

Stock Performance Indicators

Current Sentiment - ZTS

Zoetis Investor Sentiment

Greater number of Macroaxis users are at this time bullish on Zoetis. What is your take regarding investing in Zoetis? Are you bullish or bearish?
98% Bullish
2% Bearish

Also Currentnly Active

Purchased over 30 shares of
a day ago
Traded for 267.15
Purchased over 50 shares of
a day ago
Traded for 173.51
Purchased over 500 shares of
a day ago
Traded for 21.29
See also Your Current Watchlist. Please also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.